UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIZ
3926
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $1.36M | ﹤0.01% |
40,717
-8,166
| -17% | -$264K |
|
3927
Enterprise Financial Services Corp
EFSC
$2.38B
| $1.36M | ﹤0.01% |
28,142
+24,847
| +754% | +$1.1M |
|
3928
United Natural Foods
UNFI
$2.8B
| $1.36M | ﹤0.01% |
154,797
+106,707
| +222% | +$860K |
|
3929
Liberty Latin America Class A
LILA
$1.67B
| $1.35M | ﹤0.01% |
109,635
+91,031
| +489% | +$1.06M |
|
3930
Quanex
NX
$967M
| $1.35M | ﹤0.01% |
79,188
+14,473
| +22% | +$272K |
|
3931
BOK Financial
BOKF
$8.7B
| $1.35M | ﹤0.01% |
15,442
-2,608
| -14% | -$212K |
|
3932
State Street Income Allocation ETF
INKM
$75.1M
| $1.35M | ﹤0.01% |
39,344
+28,614
| +267% | +$973K |
|
|
GMLP
3933
DELISTED
Golar LNG Partners LP
GMLP
| $1.35M | ﹤0.01% |
152,633
+62,666
| +70% | +$596K |
|
|
NVTA
3934
DELISTED
Invitae Corporation
NVTA
| $1.35M | ﹤0.01% |
83,534
-305,260
| -79% | -$5.4M |
|
3935
PUT
Axalta
AXTA
$8.01B
| $1.35M | ﹤0.01% |
44,300
-83,400
| -65% | -$2.46M |
|
3936
iShares North American Natural Resources ETF
IGE
$778M
| $1.35M | ﹤0.01% |
44,708
-8,309
| -16% | -$242K |
|
3937
WisdomTree International MidCap Dividend Fund
DIM
$168M
| $1.34M | ﹤0.01% |
20,471
-456
| -2% | -$28.9K |
|
3938
TriMas Corp
TRS
$1.43B
| $1.34M | ﹤0.01% |
42,799
+3,524
| +9% | +$109K |
|
|
TVRD
3939
Tvardi Therapeutics
TVRD
$22M
| $1.34M | ﹤0.01% |
2,316
+774
| +50% | +$543K |
|
3940
PUT
Infosys
INFY
$50.9B
| $1.34M | ﹤0.01% |
130,000
| – | – |
|
|
PNF
3941
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $1.34M | ﹤0.01% |
96,776
+2,248
| +2% | +$31.9K |
|
3942
Kulicke & Soffa
KLIC
$4.53B
| $1.33M | ﹤0.01% |
49,057
-129,220
| -72% | -$3.19M |
|
3943
Kirby Corp
KEX
$7B
| $1.33M | ﹤0.01% |
14,859
+7,560
| +104% | +$626K |
|
3944
Tronox
TROX
$993M
| $1.33M | ﹤0.01% |
116,337
+48,998
| +73% | +$490K |
|
3945
Gabelli Equity Trust
GAB
$1.79B
| $1.32M | ﹤0.01% |
222,375
+18,425
| +9% | +$109K |
|
|
MFA
3946
PUT
MFA Financial
MFA
$919M
| $1.32M | ﹤0.01% |
43,200
| – | – |
|
3947
NexGen Energy
NXE
$6.91B
| $1.32M | ﹤0.01% |
1,032,429
-356,577
| -26% | -$458K |
|
3948
First Financial Corp
THFF
$962M
| $1.32M | ﹤0.01% |
28,879
+5,523
| +24% | +$244K |
|
|
BGH
3949
Barings Global Short Duration High Yield Fund
BGH
$287M
| $1.32M | ﹤0.01% |
75,260
-7,093
| -9% | -$121K |
|
3950
Alamos Gold
AGI
$13.9B
| $1.32M | ﹤0.01% |
218,778
+193,883
| +779% | +$1.06M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.